Affordable Access

Technology, Competition and the Time of Entry: Diversification Patterns in the Development of New Drugs

Authors

Abstract

This paper empirically investigates the determinants of R&D diversification strategies in the drug industry. It enriches the existing literature by proposing to look at diversification factors, which reflect market and technological proximity of an R&D project towards other projects within a firm's portfolio as well as R&D competition factors. Additionally, the characteristics of R&D in the market where a new potential product is developed affiect future product choice. The analysis is performed for products-in-development data, merged with firms' patents, which allows us to separate project proximity in market niches from technological proximity. The results of empirical estimation support an idea that R&D diversification is governed by the economies of scope as well as the escape competition motive. Moreover, it is found that competition rather than spillovers in the niche where an R&D project is developed defines firms' decisions to diversify.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Competition and new technology.

on Health affairs (Project Hope) 2005

New drugs: first time in man.

on Journal of clinical pharmacolo... November 1989

A new venture's optimal entry time

on European Journal of Operationa... Jan 01, 2002
More articles like this..